If the enhanced credits currently available to Affordable Care Act (ACA) Marketplace enrollees are allowed to expire for 2026 ...

Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...

In November, the Trump administration resurrected a Most Favored Nation (MFN) reference pricing policy, which would tie drug ...

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

This grant will help the Historic New Harmony program establish the Historic New Harmony Religious Liberty Initiative.

The University of Southern Indiana has been awarded a $2.5 million grant from Lilly Endowment Inc. to bolster the Historic ...

Historic Santa Claus Campground has received an $861,224 grant from Lilly Endowment Inc. through its Capital Project ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

Eli Lilly’s next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from ...

Elanco's monoclonal antibody therapy, Trutect, received a conditional license from the federal agency in 2023.

Treatment with Kisunla was associated with sustained clinical benefits, specifically less symptom worsening and significant amyloid clearance up to 3 years, in early symptomatic Alzheimer’s disease, ...